CJC-1295 no DAC 5mg

Description

CJC-1295 (No DAC) 5mg

CJC-1295 (No DAC) 5mg is a high-quality peptide suitable for research purposes. It is intended for controlled analytical environments where compound identity, handling, and storage consistency are required.

CJC-1295 is a synthetic peptide analogue of growth hormone-releasing hormone (GHRH) and is frequently examined for its effects on growth hormone pathways. It does not contain the Drug Affinity Complex (DAC), so it does not remain active in the system as long as its DAC-modified version. Peptides without DAC are useful for researchers studying peptide activity, hormone signalling, and receptor responses over shorter periods.

Scientists investigate CJC-1295 (without DAC) to evaluate hypotheses related to the endocrine system, peptide pharmacology, and cellular communication. Each vial is produced under strict quality control guidelines and tested to provide assurance of purity, consistency, and reliability. Every vial is securely sealed and clearly labelled for identification and traceability.

Key Features

• Contains 5mg of CJC-1295 (Without DAC)

• Research-grade quality

• Suitable for hormone and peptide research

• Tested for purity and consistency

• Manufactured under strict quality standards

• Modified GHRH(1-29) analog — four amino acid substitutions for enhanced stability

• Without DAC — no albumin binding; pulsatile GH release pattern preserved

• ≥99% purity — HPLC tested, COA provided

• 5mg research vial — lyophilised powder

• Fast UK dispatch

Specifications

• Molecular Formula: C₁₅₂H₂₅₂N₄₄O₄₂

• Molecular Weight: 3,367.97 g/mol

• Quantity: 5mg per vial

• Purity: ≥99% (HPLC)

• Form: Lyophilised powder

• Storage: −20°C long-term; 4°C post-reconstitution

For research use only. Not intended for human consumption.